RRM2 and CDC6 are novel effectors of XBP1-mediated endocrine resistance and predictive markers of tamoxifen sensitivity

David Barua, Sanjeev Gupta(Ollscoil na Gaillimhe – University of Galway)
BMC Cancer
March 30, 2023
Cited by 6


Related Papers